Document is current
Any future updates will be listed below
-
Authors
Dmytrenko, Oleg https://orcid.org/0000-0002-1165-6836
Yuan, Biao
Crosby, Kadin T. https://orcid.org/0009-0001-0201-5340
Krebel, Max https://orcid.org/0009-0006-2404-6689
Chen, Xiye
Nowak, Jakub S.
Chramiec-Głąbik, Andrzej
Filani, Bamidele https://orcid.org/0009-0000-7830-7270
Gribling-Burrer, Anne-Sophie
van der Toorn, Wiep
von Kleist, Max https://orcid.org/0000-0001-6587-6394
Achmedov, Tatjana
Smyth, Redmond P. https://orcid.org/0000-0002-1580-0671
Glatt, Sebastian https://orcid.org/0000-0003-2815-7133
Bravo, Jack P. K. https://orcid.org/0000-0003-0456-0753
Heinz, Dirk W. https://orcid.org/0009-0006-0514-1728
Jackson, Ryan N. https://orcid.org/0000-0001-7403-3794
Beisel, Chase L. https://orcid.org/0000-0003-0650-9943
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 3 November 2025
First Online: 7 January 2026
Competing interests
: O.D., K.T.C., J.P.K.B., R.N.J. and C.L.B. have filed patent applications on related technologies. W.v.d.T., M.v.K. and R.S. have filed patent applications on the warpdemux technology used as part of direct RNA sequencing. C.L.B. is a co-founder and scientific advisor of Locus Biosciences, a co-founder and officer of Leopard Biosciences, and scientific advisor to Benson Hill. The other authors declare no conflicts of interest.
